3 hours CONMED (NYSE:CNMD) Receives Buy Rating from Needham & Company LLCMarketBeat
Needham & Company LLC reaffirmed a “buy” rating and set a $97.00 target price on shares of CONMED in a report on Thursday.
XNeedham & Company LLC reaffirmed a “buy” rating and set a $97.00 target price on shares of CONMED in a report on Thursday.
X